Log In
BCIQ
Print this Print this
 

COH29

  Manage Alerts
Collapse Summary General Information
Company City of Hope
DescriptionSmall molecule ribonucleotide reductase inhibitor
Molecular Target Ribonucleotide reductase
Mechanism of ActionRibonucleotide reductase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat refractory solid tumors or those for which no standard therapy exists
Regulatory Designation
PartnerNovonco Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/20/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today